Variant report
Variant | nsv10662 |
---|---|
Chromosome Location | chr5:5107264-5110038 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191601334 | chr5:5108059-5108060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs372339852 | chr5:5108065-5108066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181689775 | chr5:5108112-5108113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs270627 | chr5:5108129-5108130 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs533618016 | chr5:5108139-5108140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531952438 | chr5:5108185-5108186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs16874713 | chr5:5108215-5108216 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs546011389 | chr5:5108235-5108236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187107185 | chr5:5108249-5108250 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs77935336 | chr5:5108252-5108253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76660559 | chr5:5108254-5108255 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs376594994 | chr5:5108277-5108278 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs77338680 | chr5:5108394-5108395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs57546252 | chr5:5108413-5108414 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs576493344 | chr5:5108414-5108415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs550605482 | chr5:5108442-5108443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543506747 | chr5:5108488-5108489 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570451147 | chr5:5108509-5108510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs539660507 | chr5:5108513-5108514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565303848 | chr5:5108518-5108519 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34948001 | chr5:5108529-5108530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs10042128 | chr5:5108554-5108555 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs566793706 | chr5:5108558-5108559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191890183 | chr5:5108584-5108585 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs140917303 | chr5:5108592-5108593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs575661311 | chr5:5108611-5108612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs544612202 | chr5:5108627-5108628 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558269827 | chr5:5108648-5108649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs187954270 | chr5:5108710-5108711 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs540853362 | chr5:5108730-5108731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs560456891 | chr5:5108736-5108737 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541420150 | chr5:5108742-5108743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs138595477 | chr5:5108773-5108774 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs115880767 | chr5:5108783-5108784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565045972 | chr5:5108822-5108823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561351117 | chr5:5108826-5108827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530469787 | chr5:5108847-5108848 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs16874715 | chr5:5108866-5108867 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs149189388 | chr5:5108882-5108883 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs115301736 | chr5:5108886-5108887 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143360804 | chr5:5108897-5108898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs189689417 | chr5:5108915-5108916 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535749240 | chr5:5108957-5108958 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs148001481 | chr5:5108959-5108960 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569161999 | chr5:5108964-5108965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs527585909 | chr5:5108968-5108969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182310089 | chr5:5109013-5109014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187971061 | chr5:5109014-5109015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568791804 | chr5:5109065-5109066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549200636 | chr5:5109077-5109078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Schizophrenia | 23813976 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:5108000-5108200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr5:5108000-5108600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr5:5108200-5115400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr5:5108400-5108800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr5:5108400-5109000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |